GDF15 and metabolism: homing in on a new therapy
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Three recent studies in mice have identified a specific receptor, GFRAL, for the known anorectic peptide GDF15, increasing the mechanistic understanding of its effect and paving the way for the development of novel anti-obesity therapeutics.
Description
Keywords
Journal Title
Nature Medicine
Conference Name
Journal ISSN
Volume Title
Publisher
Springer Nature
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as http://www.rioxx.net/licenses/all-rights-reserved